APUS
Apimeds Pharmaceuticals US, Inc.
Going-concern doubt
— flagged May 26, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not contain any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed May 26, 2026
Company with tickers: APUS
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding APUS
4 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 60,976 | $109,110 | 0.00% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 34,953 | $62,545 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 23,750 | $32,300 | 0.00% | Long | 2026-02-28 | |
| Fidelity Series Total Market Index Fund | — | 9,729 | $13,231 | 0.00% | Long | 2026-02-28 |
Showing 1–4 of 4 positions